Medical News

RSS

Newly developed technique delivers wireless power for optogenetics

A miniature device that combines optogenetics - using light to control the activity of the brain - with a newly developed technique for wirelessly powering implanted devices is the first fully internal method of delivering optogenetics.

18 Aug 2015

Vitamin D supplements may help reduce risk of falls in homebound elderly

Every year falls affect approximately one in three older adults living at home, with approximately one in 10 falls resulting in serious injury. Even if an injury does not occur, the fear of falling can lead to reduced activity and a loss of independence.

18 Aug 2015

Kessler Foundation researcher confirms link between sleep disturbances and MS-related fatigue

Kessler Foundation's Lauren Strober, PhD, explores the association of secondary fatigue and sleep disturbances in multiple sclerosis (MS). "Fatigue in multiple sclerosis: a look at the role of poor sleep" was published in Frontiers in Neurology.

18 Aug 2015

Penn experts find that health insurance websites assist patients in choosing health insurance plans

Websites for national and state health insurance marketplaces show evidence of improved efforts to assist patients in choosing health insurance plans, such as providing decision support tools, experts from the Perelman School of Medicine at the University of Pennsylvania have found.

18 Aug 2015

Studies show jumping genes more active during development of gastrointestinal cancers

Results of a trio of studies done on human cancer tissue biopsies have added to growing evidence that a so-called jumping gene called LINE-1 is active during the development of many gastrointestinal cancers.

18 Aug 2015

Chronic fatigue a long-term problem for testicular cancer survivors

A Norwegian population-based study reported in the Annals of Oncology has found a rise in the incidence of chronic fatigue a decade or more after treatment in testicular cancer survivors.

17 Aug 2015

Putaminal serotonergic innervation flags levodopa-induced dyskinesia risk

Increased serotonergic fibre innervation relative to dopaminergic fibre availability may be a potential marker of disease progression in Parkinson’s disease patients and a possible warning of levodopa-induced dyskinesia, indicates an in vivo imaging study.

17 Aug 2015

CML survey reveals patient TKI adherence, disease anxiety

Survey results suggest that chronic myeloid leukaemia patients using tyrosine kinase inhibitor therapy have good adherence to treatment but might benefit from counselling regarding their illness.

17 Aug 2015

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

Allogeneic haematopoietic stem cell transplantation can be considered for chronic- and accelerated-phase chronic myeloid leukaemia patients with prior exposure to second-generation tyrosine kinase inhibitors, say Polish researchers.

17 Aug 2015

TKI outcomes ‘unfavourable’ in young CML patients

Adolescent and young adult patients with chronic myeloid leukaemia may have an unfavourable outcome on tyrosine kinase inhibitor therapy compared with their older counterparts, suggests a study of Japanese patients.

17 Aug 2015

New OTEMTO phase three results show potential improvement to quality of life for COPD patients

Boehringer Ingelheim announced the publication of new data from the Phase IIIb OTEMTO® 1&2 trials (NCT01964352/NCT02006732), which show Spiolto® Respimat® (tiotropium/olodaterol) provides consistent, clinically meaningful improvements in quality of life versus placebo in patients with COPD

17 Aug 2015

Staffordshire and Stoke on Trent Partnership aims to be the first NHS Trust to review all deaths

Staffordshire and Stoke on Trent Partnership NHS Trust, the UK’s biggest provider of community health and adult social care, is aiming to be the first NHS Trust in the country to review all deaths.

17 Aug 2015

Mayo Clinic study highlights LumaGEM MBI as cost-effective tool for detecting women with dense breast tissue

A recent study conducted by Mayo Clinic has determined that the addition of Molecular Breast Imaging (MBI) for women with dense breast tissue resulted in a lower cost per cancer detected than screening with mammography alone.

17 Aug 2015

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced an increase in funding of up to CDN$287,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to support an ongoing research project.

17 Aug 2015

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

Genomic Health, Inc. today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued its final local coverage determination (LCD) approving coverage of the Oncotype DX prostate cancer test for qualified Medicare patients throughout the United States.

17 Aug 2015

NBTY signs agreement to acquire Dr. Organic

NBTY, Inc., a global leader in vitamins, nutritional supplements and sports nutrition, today announced that it has entered into an agreement to acquire Dr. Organic, a leading naturally inspired skincare line in the UK. The deal is subject to customary closing conditions, and is expected to close later this year.

17 Aug 2015

Omeros plans to file patent infringement lawsuit against Par

Omeros Corporation today, in response to investor questions, announced that it plans to file a patent infringement lawsuit against Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, LLC in response to the Abbreviated New Drug Application (ANDA) filed by Par seeking FDA approval to market a generic version of Omeros' commercial drug Omidria (phenylephrine and ketorolac injection) 1%/0.3%.

17 Aug 2015

NanoViricides speeds up HerpeCide drug development program

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reports that it is accelerating its HerpeCide drug development program.

17 Aug 2015

New ISCO-SCCA collaboration to elevate standard of monthly virtual personalized tumor board

The Idaho Society of Clinical Oncology held its annual Board of Directors retreat in Sun Valley, ID on July 24-26, 2015. The focus for the retreat was how to discuss strategies to improve the care of cancer patients in Idaho. During the meeting, ISCO board announced a partnership with the Seattle Cancer Care Alliance to collaborate with ISCO's monthly virtual personalized tumor board.

17 Aug 2015

GlySens secures FDA approval to extend current human clinical evaluation of fully implanted CGM system

GlySens Incorporated announced today that it has secured FDA approval for extending the current human clinical evaluation of its fully implantable continuous glucose monitoring system (the ICGM System) from the originally approved six-month duration to the system's commercially-intended operational duration of twelve months.

17 Aug 2015

Medical News

Newly developed technique delivers wireless power for optogenetics

Vitamin D supplements may help reduce risk of falls in homebound elderly

Kessler Foundation researcher confirms link between sleep disturbances and MS-related fatigue

Penn experts find that health insurance websites assist patients in choosing health insurance plans

Studies show jumping genes more active during development of gastrointestinal cancers

Chronic fatigue a long-term problem for testicular cancer survivors

Putaminal serotonergic innervation flags levodopa-induced dyskinesia risk

CML survey reveals patient TKI adherence, disease anxiety

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

TKI outcomes ‘unfavourable’ in young CML patients

New OTEMTO phase three results show potential improvement to quality of life for COPD patients

Staffordshire and Stoke on Trent Partnership aims to be the first NHS Trust to review all deaths

Mayo Clinic study highlights LumaGEM MBI as cost-effective tool for detecting women with dense breast tissue

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

NBTY signs agreement to acquire Dr. Organic

Omeros plans to file patent infringement lawsuit against Par

NanoViricides speeds up HerpeCide drug development program

New ISCO-SCCA collaboration to elevate standard of monthly virtual personalized tumor board

GlySens secures FDA approval to extend current human clinical evaluation of fully implanted CGM system

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News